My Work
Scroll below to see a sample of a white paper and outcomes report. Most of the deliverables I create for clients are under NDA, but I can provide the link and discuss my approach upon further inquiry.
A brief overview of some CME activities I created for educational providers and professional societies:
- Simulation case: CAR-T therapy for R/R diffuse large B-cell lymphoma. Treatment decision for CAR-T requires an individualized approach and vigilant monitoring for acute and late toxicities. This interactive case walks through selecting an appropriate CAR-T based on clinical evidence and patient factors and managing toxicities for a patient with R/R DLBCL. (Target audience: hematologists/oncologists, nurse practitioners, physician assistants, nurses, and pharmacists).
- Role-play case study: Eosinophilic esophagitis diagnosis and long-term management. This role-play case between a gastroenterologist and a young patient actor navigates the patient’s journey from diagnosis to selecting treatment using a shared decision-making framework. (Target audience: pediatric and adult gastroenterologists, NPs, and PAs)
- Case study: Asparaginase-based regimen for an adolescent and young adult (AYA) patient with acute lymphoblastic leukemia (ALL). Asparaginase is an important component of treatment regimen of (is it for or of) ALL treatment and requires careful management. In this case study, a pediatric nurse practitioner walks through the selection of asparaginase treatment for an adolescent patient, the management of silent inactivation, and the prognostic value of minimal residual disease. (Target audience: pediatric nurses, nurses, NPs, and PAs)
- Panel discussion on reducing risk of recurrence in early breast cancer (EBC). Adjuvant CDK4/6 inhibitors with endocrine therapy have demonstrated efficacy in reducing the risk of recurrence in high-risk patients with HR-positive, HER2-negative EBC. An oncologist and a nurse practitioner discuss patient selection criteria for CDK4/6 inhibitors and strategies to manage side effects to improve treatment adherence and outcomes in patients with HR+, HER2- EBC. (Target audience: oncologists, gynecologic oncologists, NPs, PAs, nurses, and pharmacists.)
- Diagnosis and optimal care of patients with hepatitis B virus infection. HBV remains the leading cause of hepatocellular carcinoma worldwide. In this webcast, an infectious specialist discusses risk factors for HBV infection, new screening and testing recommendations for optimal diagnosis, emerging treatments, and culturally competent care for patients with chronic hepatitis B. (Target audience: hepatologists/gastroenterologists, primary care physicians, infectious disease specialists, NPs, and PAs)
- New and emerging antifungal agents for the management of invasive fungal infections (IFIs). This article, along with expert insights from an infectious disease specialist, illustrates the clinical implications of newer treatment options for IFIs and strategies to manage antifungal resistance. (Target audience: infectious disease specialists, pulmonologists, pediatricians, primary care physicians, NPS, PAs, nurses, and pharmacists).
- Series of slide decks for the EURETINA IME program on geographic atrophy, dry age-related macular degeneration, and strategies for patient-centered communication to optimize adherence to intravitreal injection.
Series of eLearning modules on presbyopia and digital operating room for the European Society of Cataract & Refractive Surgeons
- Strategies for optimal patient communication and for maximizing patient satisfaction with a presbyopia-correcting procedure
- Review of the key aspects of the digital operating room and a surgeon’s personal experience with the digital operating room
- Strategies for a smooth transition from traditional to digital workflow, leading to enhanced workflow efficiency and surgeons’ comfort during surgeries
